KMT2A and acute lymphoblastic leukemia: Several studies have shown that patient-derived T-ALL cells are almost as sensitive to Btz as MLL–AF4 cells, and more sensitive than cells derived from subtypes of B-ALL that do not bear MLL–AF4 fusion6,7.